Home NDC 70518-1363 acyclovir
Product NDC 70518-1363
11-digit product format 705181363
Labeler code 70518
Product ID 70518-1363_4bd3791a-9cbb-3c48-e063-6394a90a6d7a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acyclovir
Dosage form TABLET
Route ORAL
Labeler REMEDYREPACK INC.
Application ANDA204314
Marketing category ANDA
Marketing start 2018-08-09
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base acyclovir
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 400 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197311
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-1363-0 acyclovir 15 in 1 BOTTLE, PLASTIC TABLET 15 8 70518-1363-1 acyclovir 30 in 1 BOTTLE, PLASTIC TABLET 30 8 70518-1363-2 acyclovir 30 in 1 BLISTER PACK TABLET 30 8
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70518-1363-0 70518136300 15 TABLET in 1 BOTTLE, PLASTIC (70518-1363-0) 15 tablet 2018-08-09 No No Historical 70518-1363-1 70518136301 30 TABLET in 1 BOTTLE, PLASTIC (70518-1363-1) 30 tablet 2018-12-27 No No Historical 70518-1363-2 70518136302 30 TABLET in 1 BLISTER PACK (70518-1363-2) 30 tablet 2026-02-17 No No Historical